97314 ⎘
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Non-glycosylated transferrin expressed in monocots
#2702Compositions and methods for identifying enzyme and transport protein inhibitors
#2703Amino acid sequences which enhance peptide conjugate solubility
#2704Tetravalent influenza vaccine and use thereof
#2705USE OF E. COLI SURFACE ANTIGEN 3 SEQUENCES FOR THE EXPORT OF HETEROLOGOUS ANTIGENS
#2706RTEF-1 variants and uses thereof
#2707Protein substance having triple helix structure and manufacturing method therefor
#2708USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS
#2709Cells and methods for producing blocking antibodies to human RANKL
#2710EXPRESSION VECTORS ABLE TO ELICIT IMPROVED IMMUNE RESPONSE AND METHODS OF USING SAME
#2711Compositions and method for CaMKII inhibitors and uses thereof
#2712Optimizing glycan processing in plants
#2713CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
#2714FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same
#2715DELIVERY OF THERAPEUTIC AGENTS TO THE BONE
#2716Independently Inducible System of Gene Expression
#2717Wnt Antagonists and Methods of Treatment and Screening
#2718Processing of recombinant human G-CSF precursor
#2719Insulin-like growth factor 1 receptor binding peptides
#2720Polynucleotides encoding BSL2vcvc-lg
#2721Viral Sequences and Uses Thereof
#2722Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
#2723Compositions and methods for identifying antigens which elicit an immune response
#2724TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY
#2725Capsular gram-positive bacteria bioconjugate vaccines
#2726vectored vaccines against and methods of use
#2727RECOMBINANT NELL PROTEIN PRODUCTION
#2728Process for preparing inclusion body-forming protein
#2729Kit for the optimisation of protein synthesis/secretion
#2730Method of obtaining a purified, biologically active heterologous protein
#2731Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
#2732Human Notch3 based fusion proteins as decoy inhibitors of Notch3 signaling
#2733Internalizing ErbB2 antibodies
#2734Chimeric peptides for the regulation of GTPases
#2735Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
#2736Kits for detecting rank
#2737METHODS AND COMPOSITIONS USING FGF23 FUSION PPOLYPEPTIDES
#2738Cells producing glycoproteins having altered glycosylation patterns and method and use thereof
#2739Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria
#2740Fiducial markers for augmented reality
#2741MINIGENE
#2742Enterovirus type 71 protein and method for production
#2743Mammalian Cytokines; Related Reagents and Methods
#2744Light-Activated Proton Pumps and Applications Thereof
#2745Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family
#2746Methods, chimeric polypeptides, polynucleotides and cells for producing bioplastics
#2747COMPOSITIONS AND METHODS FOR TREATING HUMAN PAPILLOMAVIRUS-MEDIATED DISEASE
#2748Polyol oxidases
#2749Fusion proteins and use thereof for preparing hepatitis C vaccines
#2750NOVEL ANTI-ALLERGIC AGENTS
#2751Mutated nucleotide sequences of batroxobin, mutated α factor secretion signal sequence and processes for preparing batroxobin using the same
#2752EXPRESSION SYSTEM COMPOSITIONS AND METHODS
#2753MODIFIED GROWTH HORMONE
#2754METHOD FOR A PRODUCTION OF A RECOMBINANT PROTEIN USING YEAST CO-EXPRESSION SYSTEM
#2755Altered Antibody FC Regions and Uses Thereof
#2756Methods and composition for secretion of heterologous polypeptides
#2757Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
#2758Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope
#2759HIV-1 GP41 neutralization domain and use thereof
#2760Method of inhibiting osteoclast activity
#2761PHAGE DISPLAYING SYSTEM EXPRESSING SINGLE CHAIN ANTIBODY
#2762RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
#2763Mammalian cell culture processes for protein production
#2764Vector
#2765Multiple domain proteins
#2766POLYNUCLEOTIDES ENCODING CLASS II CYTOKINE RECEPTOR-7
#2767METHODS FOR TREATING BLOOD COAGULATION DISORDERS
#2768Method for the secretory production of heterologous protein in
#2769Use of an aspartic protease (NS24) signal sequence for heterologous protein expression
#2770Antibody-producing transgenic silkworms and methods for producing the same
#2771BACTERIAL LEADER SEQUENCES FOR INCREASED EXPRESSION
#2772Promoter-encoding DNA fragment, recombinant vector, recombiant transformant, and uses thereof
#2773Compositions of humanized notch fusion proteins and methods of treatment
#2774Recombinant elastase proteins and methods of manufacturing and use thereof
#2775REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS
#2776METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS WITH SUPRAPHYSIOLOGICAL DOSES OF MANNAN-BINDING LECTIN (MBL) AND FICOLIN-MBL FUSION PROTEINS
#2777IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#2778Targeted modification of chromatin structure
#2779Regulated apoptosis
#2780METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#2781DNA REPAIR POLYPEPTIDES AND METHODS OF DELIVERY AND USE
#2782METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#2783Subunit vaccine for aquaculture
#2784RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ
#2785Production of collagen in the milk of transgenic mammals
#2786Reagents and Methods for Producing Bioactive Secreted Peptides
#2787Expression of Human Serum Albumin in Plastids
#2788Process for producing transglutaminase
#2789Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions
#2790TAT SIGNAL PEPTIDES FOR PRODUCING PROTEINS IN PROKARYOTES
#2791DNA immunization protocols
#2792Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
#2793Chimeric flavivirus vaccines
#2794Antibody fusion proteins with a modified FcRn binding site
#2795Endoglucanases
#2796Expression of Genes from Gram Negative Bacteria in Fungi
#2797mTOR ligands and polynucleotides encoding mTOR ligands
#2798Vector particles for targeting CD34+ cells
#2799Recombinant baculovirus vaccine
#2800Her-2/neu DNA vaccine having anti-cancer activity
#2801PROTEIN D - AN IGD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE
#2802Cupredoxin derived transport agents and methods of use thereof
#2803DR6 ANTAGONISTS AND USES THEREOF IN TREATING NEUROLOGICAL DISORDERS
#2804Collectin fusion proteins comprising TNF or trail
#2805Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopes
#2806Use of gp130 activators in diabetic neuropathy
#2807Fusion proteins of mycobacterium tuberculosis
#2808Fusion proteins of
#2809Receptor-based interaction trap
#2810Nucleic acid modules for expression and tagging of membrane proteins and methods of use
#2811BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
#2812Signaling peptides
#2813Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
#2814Enhancing the effect of therapeutic proteins on the central nervous system
#2815METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
#2816METHODS OF ENHANCING PROTEIN INCORPORATION INTO VIRUS LIKE PARTICLES
#2817In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
#2818METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#2819Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
#2820Mammalian Cell Membrane Proteins; Related Reagents
#2821Enterovirus type 71 protein and method for production
#2822BSL2v1c2 polypeptides
#2823Optimizing glycan processing in plants
#2824Recombinant vaccines and use thereof
#2825Altered Antibody Fc Regions and Uses Thereof
#2826METHODS AND COMPOSITIONS RELATED TO APOBEC-1 EXPRESSION
#2827Multivalent antibody constructs
#2828POLYNUCLEOTIDES ENCODING CLASS II CYTOKINE RECEPTOR-7
#2829COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF ORGANOPHOSPHATASES
#2830ANTIBODIES TO MAMMALIAN CYTOKINE-LIKE FACTOR 7
#2831Targeted therapeutic proteins
#2832METHODS OF TREATING BONE DISEASE USING VASCULAR ENDOTHELIAL GROWTH FACTOR FUSION CONSTRUCTS
#2833Methods of using Fc-cytokine fusion proteins
#2834METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS
#2835Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
#2836Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino Acids
#2837Bacterial leader sequences for increased expression
#2838Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
#2839ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#2840Antimicrobial peptides and uses thereof
#2841Alpha Factor Signal Peptide For Producing a Polypeptide
#2842Reducing the immunogenicity of fusion proteins
#2843Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
#2844Delivery of therapeutic agents to the bone
#2845Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
#2846PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#2847Fungal cell wall synthesis gene
#2848Recombinant baculovirus vaccine
#2849Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
#2850Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses
#2851Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling
#2852Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
#2853PIR1 secretion signal peptide for recombinant protein expression and PIR1 and PIR2 anchor domain peptides for recombinant surface display
#2854MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS
#2855NUCLEAR TRANSPORT AGENT AND METHOD FOR PRODUCING SAID AGENT
#2856Methods for producing secreted polypeptides having biological activity
#2857Directed evolution of novel binding proteins
#2858Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same
#2859Method for generating tethered proteins
#2860Xylanases, nucleic acids encoding them and methods for making and using them
#2861SIGNAL SEQUENCES AND CO-EXPRESSED CHAPERONES FOR IMPROVING PROTEIN PRODUCTION IN A HOST CELL
#2862PHARMACEUTICAL COMPOSITIONS COMPRISING ELP FUSION PROTEINS
#2863Inflammation models in neurodegenerative and arthritic disorders
#2864OMP P6 VACCINE FOR TREATING AND PREVENTING CHLAMYDIA INFECTION
#2865Chimeric peptides for the regulation of GTPases
#2866TARGETED THERAPEUTIC PROTEINS
#2867Selection system
#2868Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
#2869Method of secretory expression of lysostaphin in at high level
#2870Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
#2871Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein
#2872Methods of treating using hormone-albumin fusion proteins
#2873Proteins with an attached short peptide of acidic amino acids
#2874Secreted and transmembrane polypeptides and nucleic acids encoding the same
#2875USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY
#2876DNA-BASED VACCINATION OF RETROVIRAL-INFECTED INDIVIDUALS UNDERGOING TREATMENT
#2877Recombinant elastase proteins and methods of manufacturing and use thereof
#2878Avian leukosis viruses and polypeptide display
#2879METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#2880Modified Cyanovirin-N Polypeptide
#2881MOLECULE AND CHIMERIC MOLECULES THEREOF
#2882Chimeric Non-Human Animal and Use Thereof
#2883polypeptides and corresponding DNA fragments and uses thereof
#2884Activin-ActRIIa antagonists and uses for treating multiple myeloma
#2885APOLIPOPROTEIN ANALOGUES
#2886SCREENING PROTEINASE MODULATORS USING A CHIMERIC PROTEIN AND SKI-I PROPROTEIN CONVERTASE SUBSTRATES AND INHIBITORS
#2887Protease screening methods and proteases identified thereby
#2888Fungal cell wall synthesis gene
#2889RTEF-1 variants and the use thereof for inhibition of angiogenesis
#2890Methods of selecting internalizing antibodies
#2891Expression vector for secreting antibody fragment using signal sequence and method for mass-producing antibody fragment
#2892COMPOSITIONS AND METHODS OF USING CAPSID PROTEIN FROM FLAVIVIRUSES AND PESTIVIRUSES
#2893FUNGAL CELL WALL SYNTHESIS GENE
#2894Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
#2895Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
#2896Methods and Compositions Related to APOBEC-1 Expression
#2897ANTIBODIES TO CLASS II CYTOKINE RECEPTOR-7
#2898Enhancing protein expression
#2899Method of producing sugar chain using human G4 polypeptide
#2900Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
#2901Regulated transcription of targeted genes and other biological events
#2902Vector expressing n-deacetylase/n-sulfotransferase 2
#2903Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
#2904PICHIA METHANOLICA SECRETORY SIGNAL
#2905Method for targeting lysosomal enzymes
#2906Compositions and methods for studying and treating inflammatory diseases and disorders
#2907METHODS AND COMPOSITIONS FOR PROTEIN PURIFICATION
#2908Avidin mutants
#2909Targeted modification of chromatin structure
#2910Vector
#2911Methods for interfering with rank signaling
#2912PRODUCTION OF A SOLUBLE NATIVE FORM OF RECOMBINANT PROTEIN BY THE SIGNAL SEQUENCE AND SECRETIONAL ENHANCER
#2913Receptor based antagonists and methods of making and using
#2914Chimeric G protein based rabies vaccine
#2915Chimeric immunogens
#2916Chimeric immunogens
#2917Polypeptides and nucleic acids encoding same
#2918COMPOUNDS AND METHODS FOR MODULATING THE IMMUNE RESPONSE AGAINST ANTIGENS
#2919Polyol oxidases
#2920COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#2921DAP12 nucleic acids
#2922Human Therapeutic Cells Secreting Nerve Growth Factor
#2923Methods for producing secreted polypeptides
#2924YEAST CELLS EXPRESSING MODIFIED G PROTEINS AND METHODS OF USE THEREFOR
#2925Fungal cell wall synthesis gene
#2926PROCESS FOR THE FERMENTATIVE PRODUCTION OF PROTEINS
#2927Mycobacteria expressing HIV-1 and malaria antigens
#2928Xylanases, nucleic acids encoding them and methods for making and using them
#2929DNA vaccine
#2930Fusion proteins of
#2931Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
#2932Methods and compositions for targeting proteins across the blood brain barrier
#2933NUCLEIC ACIDS ENCODING CHIMERIC POLYPEPTIDES ALLOWING EXPRESSION OF PLANT-NOXIOUS PROTEINS
#2934Modified peptides and their uses
#2935Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album
#2936mTOR ligands and polynucleotides encoding mTOR ligands
#2937Methods and Compositions for Detecting Target Sequences
#2938Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
#2939Process for producing prenyl alcohols
#2940DNA, vector, transformant and method for producing APA protein
#2941Apo-3 ligand polypeptide
#2942HER-2/neu fusion proteins
#2943Immunization of dairy cattle with GapC protein against infection
#2944FEN Endonucleases
#2945Method of treating a muscle-related condition with modified IGF1 polypeptides
#2946METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS
#2947Bacterial leader sequences for increased expression
#2948Microbially expresses xylanases and their use as feed additives and other uses
#2949Tool for the transfer and production of proteins using the pseudomonas type III secretion system
#2950SP16 protein
#2951VECTOR SYSTEM
#2952COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#2953COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#2954Apo-3 ligand polypeptide
#2955MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS
#2956Fungal cell wall synthesis gene
#2957DNA construct encoding CE7-specific chimeric T cell receptor
#2958Methods and Compositions for Detecting Target Sequences
#2959Humanized immunoglobulins
#2960Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
#2961Compositions and methods for identifying antigens which elicit an immune response
#2962cDNA corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses
#2963Internalizing ErbB2 antibodies
#2964Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene
#2965Factor C for treating gram-negative bacterial infection
#2966Vectors for expressing in vivo biotinylated recombinant proteins
#2967Means for stimulation and activation of hair growth by il-15
#2968PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#2969ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#2970Chimeric immunogens
#2971Chimeric immunogens
#2972Method of treatment comprising administration of a cytokine antagonist molecule
#2973Chimeric immunogens
#2974Kits for detecting rank nucleic acids
#2975Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
#2976Nucleic acids encoding growth hormone with a modified RSP sorting signal
#2977Method for producing CE7-specific redirected immune cells
#2978Pseudotyped baculovirus to stimulate immunogenicity against avian influenza
#2979HUMAN CDNAS AND PROTEINS AND USES THEREOF
#2980Infectious recombinant paramyxovirus from antigenomic cDNA
#2981CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
#2982Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
#2983Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene
#2984Methods and Compositions for Protein Expression and Purification
#2985Lectins for Analyzing Sugar Chains and Method of Using the Same
#2986Conformational and topological protein regulation
#2987Transient immortalization
#2988PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#2989DNA encoding the human serine protease EOS
#2990ENHANCING THE EFFECT OF THERAPEUTIC PROTEINS ON THE CENTRAL NERVOUS SYSTEM
#2991Antibodies to HTEEB42 protein
#2992Modified HPV E6 and E7 genes and proteins useful for vaccination
#2993MODIFIED HPV E6 AND E7 GENES AND PROTEINS USEFUL FOR VACCINATION
#2994Fusion proteins of
#2995Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
#2996Methods for production of receptor and ligand isoforms
#2997Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence
#2998Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
#2999Fusion proteins based upon somatostatin receptors
#3000Innate immune system-directed vaccines